Connect with us
We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Birth Defects

Breaking Down Barriers: Towards Gene-Targeting Drugs for Brain Diseases

Getting therapeutic drugs past the blood-brain barrier has long been a major challenge in treating brain diseases. Now, researchers have explored how cholesterol-modified heteroduplex oligonucleotides (Chol-HDOs) enhance drug delivery to the brain. Their study reveals that Chol-HDOs bind tightly to serum proteins, allowing them to persist in the bloodstream and cross into brain tissue. These findings offer insights into gene-targeting therapies and could help develop treatments for conditions like Alzheimer’s disease.

Avatar photo

Published

on

Breaking Down Barriers: Towards Gene-Targeting Drugs for Brain Diseases

The human brain is a complex and intricate organ that has long been a challenge to treat when it comes to diseases like Alzheimer’s, Parkinson’s, and brain cancers. One of the major obstacles in delivering therapeutic drugs to the brain is the blood-brain barrier (BBB), a protective layer that restricts the passage of molecules from the bloodstream into the brain.

To overcome this hurdle, researchers at Tokyo University of Science have been exploring new ways to deliver gene-targeting drugs, specifically antisense oligonucleotides (ASOs) and heteroduplex oligonucleotides (HDOs), directly to the brain. In a recent study published in the Journal of Controlled Release, the team led by Professor Makiya Nishikawa demonstrated that modifying HDOs with cholesterol molecules (Chol-HDOs) could improve their stability and specificity, allowing them to penetrate the cerebral cortex beyond the blood vessels.

The key to this success lies in how Chol-HDOs interact with proteins in the bloodstream. Unlike ASOs and HDOs, which bind electrostatically to serum proteins with low affinity and are taken up by cells, Chol-HDOs bind tightly to serum proteins, including lipoproteins, via hydrophobic interactions. This strong binding results in slow clearance from the bloodstream, allowing Chol-HDOs to remain in circulation for a longer period.

The researchers also showed that inhibiting scavenger receptors in cells reduces the uptake of both ASOs and Chol-HDOs in the liver and kidneys, shedding light on how these compounds are taken up by different organs. This finding has significant implications for the design of brain-targeting drugs based on Chol-HDOs.

With over 55 million people living with dementia worldwide and 300,000 cases of brain cancer reported annually, the potential therapeutic applications of modified HDOs are vast. The possibility of efficiently delivering ASOs and other nucleic acid-based drugs to the brain may lead to the development of treatments for brain diseases with significant unmet medical needs.

This study provides valuable insight into how brain-targeting drugs could be designed based on Chol-HDOs, paving the way for a new generation of compounds that effectively target brain diseases. As research continues, we can expect modified HDOs to offer hope to millions of patients and their families around the world.

Autism

CRISPR-edited stem cells hold key to understanding autism spectrum disorder

A team at Kobe University has created a game-changing resource for autism research: 63 mouse embryonic stem cell lines, each carrying a genetic mutation strongly associated with the disorder. By pairing classic stem cell manipulation with precise CRISPR gene editing, they ve built a standardized platform that mirrors autism-linked genetic conditions in mice. These models not only replicate autism-related traits but also expose key dysfunctions, like the brain s inability to clean up faulty proteins.

Avatar photo

Published

on

CRISPR technology has revolutionized genetics research, enabling scientists to edit genes with unprecedented precision. Recently, researchers at Kobe University developed a new method for modifying embryonic stem cells using CRISPR, creating a bank of 63 mouse embryonic stem cell lines containing the mutations most strongly associated with autism spectrum disorder (ASD). This breakthrough achievement has shed light on the hidden causes of ASD.

For decades, scientists have known that genetics play a significant role in the development of ASD. However, pinpointing the precise cause and mechanism remained elusive due to the lack of a standardized biological model for studying the effects of different mutations associated with the disorder. To address this challenge, Takumi Toru and his team at Kobe University embarked on a journey to create a reliable model by combining conventional manipulation techniques for mouse embryonic stem cells with CRISPR gene editing.

The new method proved highly efficient in making genetic variants of these cells, allowing the researchers to produce 63 mouse embryonic stem cell lines containing the mutations most strongly associated with ASD. These cell lines were further developed into various cell types and tissues, even generating adult mice with their genetic variations. The analysis of these cell lines revealed that autism-causing mutations often result in neurons being unable to eliminate misshapen proteins.

This finding is particularly interesting since the local production of proteins is a unique feature in neurons, and a lack of quality control of these proteins may be a causal factor of neuronal defects in ASD. Takumi expects that this achievement will be an invaluable resource for researchers studying autism and searching for drug targets. Moreover, the genetic variants studied are also implicated in other neuropsychiatric disorders such as schizophrenia and bipolar disorder, making this library potentially useful for studying these conditions as well.

This research was funded by various organizations, including the Japan Society for the Promotion of Science and the National Center of Neurology and Psychiatry. The study demonstrates the potential of CRISPR technology to reveal the hidden causes of complex diseases like ASD, paving the way for future discoveries and treatments.

Continue Reading

Back and Neck Pain

Unveiling the Secrets of the Universe: The Largest-ever Map Reveals 10x More Early Galaxies Than Expected

An international team of scientists has unveiled the largest and most detailed map of the universe ever created using the James Webb Space Telescope, revealing nearly 800,000 galaxies stretching back to almost the beginning of time. The COSMOS-Web project not only challenges long-held beliefs about galaxy formation in the early universe but also unexpectedly revealed 10 times more galaxies than anticipated along with supermassive black holes Hubble couldn t see.

Avatar photo

Published

on

The COSMOS-Web field, a vast map of the universe, has been released to the public, and it’s a game-changer. The largest-ever map of the cosmos, built with data collected by the James Webb Space Telescope (JWST), consists of imaging and a catalog of nearly 800,000 galaxies spanning nearly all of cosmic time.

The goal of the COSMOS-Web collaboration was to create this deep field of space on a physical scale that far exceeded anything that had been done before. “If you had a printout of the Hubble Ultra Deep Field on a standard piece of paper,” said UC Santa Barbara physics professor Caitlin Casey, “our image would be slightly larger than a 13-foot by 13-foot-wide mural, at the same depth.” That’s what we’re looking at here – a cosmic neighborhood that’s truly breathtaking.

The COSMOS-Web composite image reaches back about 13.5 billion years, covering about 98% of all cosmic time. The researchers wanted to see not just some of the most interesting galaxies at the beginning of time but also to get a wider view of cosmic environments that existed during the early universe, when the first stars, galaxies, and black holes formed.

And what a big surprise it turned out to be! Before JWST turned on, Casey said they made their best predictions about how many more galaxies the space telescope would see. But the best measurements from Hubble suggested that galaxies within the first 500 million years would be incredibly rare. “It makes sense,” she explained – “the Big Bang happens and things take time to gravitationally collapse and form, and for stars to turn on.”

But with JWST, they see roughly 10 times more galaxies than expected at these incredible distances. And it’s not just seeing more; they’re also seeing different types of galaxies and black holes that were previously invisible.

While the COSMOS-Web images and catalog answer many questions astronomers have had about the early universe, they also spark more questions. “Since the telescope turned on we’ve been wondering ‘Are these JWST datasets breaking the cosmological model?'” Casey said. “Because the universe was producing too much light too early; it had only about 400 million years to form something like a billion solar masses of stars.”

In releasing the data to the public, the hope is that other astronomers from all over the world will use it to further refine our understanding of how the early universe was populated and how everything evolved to the present day. The dataset may also provide clues to other outstanding mysteries of the cosmos, such as dark matter and physics of the early universe that may be different from what we know today.

“A big part of this project is the democratization of science and making tools and data from the best telescopes accessible to the broader community,” Casey said. The data was made public almost immediately after it was gathered, but only in its raw form, useful only to those with specialized technical knowledge and supercomputer access to process and interpret it.

The COSMOS collaboration has worked tirelessly for the past two years to convert raw data into broadly usable images and catalogs. In creating these products and releasing them, the researchers hope that even undergraduate astronomers could dig into the material and learn something new.

“Because the best science is really done when everyone thinks about the same data set differently,” Casey said. “It’s not just for one group of people to figure out the mysteries.”

For the COSMOS collaboration, the exploration continues. They’ve headed back to the deep field to further map and study it. “We have more data collection coming up,” she said. “We think we have identified the earliest galaxies in the image, but we need to verify that.”

Continue Reading

Autism

The Elusive Science of Tickling: Unraveling the Mysteries of a 2000-Year-Old Enigma

How come you can’t tickle yourself? And why can some people handle tickling perfectly fine while others scream their heads off? Neuroscientists argue that we should take tickle research more seriously.

Avatar photo

Published

on

The science of tickling has been shrouded in mystery for over 2000 years, leaving even the great philosophers Socrates and Charles Darwin baffled. Despite its ubiquity in human interaction, from playful teasing between parents and children to social bonding and emotional expression, the intricacies of tickling remain poorly understood. Neuroscientist Konstantina Kilteni argues that it’s time to take tickle research seriously, shedding light on the complex interplay of motor, social, neurological, developmental, and evolutionary aspects involved.

One of the most intriguing questions surrounding tickling is why we can’t tickle ourselves. Our brain appears to distinguish between self-induced and external stimuli, effectively “switching off” the tickling reflex when we know exactly where and when we’ll be tickled. This phenomenon has sparked interest in understanding what happens in our brain when we’re subjected to ticklish sensations.

Research suggests that people with autism spectrum disorder (ASD) perceive touches as more ticklish than those without ASD, offering a unique window into differences in brain development and function between individuals with and without the condition. Investigating this difference could provide valuable insights into the neurobiology of ASD and potentially inform strategies for better understanding and supporting individuals on the autism spectrum.

From an evolutionary perspective, the purpose and significance of tickling remain unclear. Kilteni notes that even apes like bonobos and gorillas exhibit responses to ticklish touches, while rats have been observed displaying similar behaviors. These observations raise questions about the role of tickling in human evolution and development, as well as its potential functions in social bonding and emotional expression.

To tackle these questions, Kilteni has established a specialized lab dedicated to studying tickling, where researchers can control and replicate various types of ticklish stimuli using mechanical devices like the “tickling chair.” By meticulously recording brain activity and physical reactions such as heart rate, sweating, breathing, laughter, and screaming responses, scientists hope to unlock the secrets of tickling and shed light on its significance in human biology and behavior.

As research continues to unravel the mysteries of tickling, it’s clear that this seemingly simple phenomenon holds a wealth of complexity and intrigue. By taking tickle research seriously, scientists like Kilteni aim to reveal new insights into human brain development, social bonding, emotional expression, and even the intricacies of ASD. The journey ahead promises to be fascinating, as we continue to explore the elusive science of tickling.

Continue Reading

Trending